Physician

Stephen D Antrobus, M.D.

According to 2025 Medicare claims, Stephen Antrobus, M.D. (NPI: 1629116553) practices plastic and reconstructive surgery in the Baton Rouge, LA market, with the plurality of this provider's patient population coming from E. Baton Rouge, LA. This provider's primary affiliated billing organization is MOHS SURGERY SPECIALISTS, LLC (NPI: 1871626903; TIN: 201656195) and primary practice location at 70809-3739.

Antrobus' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 474 traditional Medicare patients, billed 1,661 HCPCS/CPT codes, and received $487,006 in Medicare payments. The top billing code was 15260 (Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less). Part D data shows 1,099 prescription claims across 833 beneficiaries totaling $2,802 in drug costs, led by Cephalexin (Cephalexin). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$315K$630K2015 Medicare payment: $628,211 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $579,418 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $628,207 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $563,279 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $629,504 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $548,439 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $422,582 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $478,154 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $524,454 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $487,006 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155642,557$628,211
20165212,259$579,418
20175412,136$628,207
20184561,914$563,279
20195112,089$629,504
20204561,802$548,439
20213791,394$422,582
20224341,612$478,154
20234681,749$524,454
20244741,661$487,006

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.9K$3.8K2015 Drug cost: $3,842 (USD; Tot_Drug_Cst)2016 Drug cost: $3,021 (USD; Tot_Drug_Cst)2017 Drug cost: $3,430 (USD; Tot_Drug_Cst)2018 Drug cost: $3,513 (USD; Tot_Drug_Cst)2019 Drug cost: $3,437 (USD; Tot_Drug_Cst)2020 Drug cost: $2,762 (USD; Tot_Drug_Cst)2021 Drug cost: $2,367 (USD; Tot_Drug_Cst)2022 Drug cost: $2,832 (USD; Tot_Drug_Cst)2023 Drug cost: $2,824 (USD; Tot_Drug_Cst)2024 Drug cost: $2,802 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015653880$3,842
2016555768$3,021
2017625850$3,430
2018563785$3,513
2019661926$3,437
2020577810$2,762
2021567762$2,367
2022627829$2,832
20237491,013$2,824
20248331,099$2,802

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
15260Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less9899$702
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks460629$390
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks161270$294
12052Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm197208$113
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more9696$82

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CephalexinCephalexin8132,448$1,917
Doxycycline MonohydrateDoxycycline Monohydrate136437$513
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen118234$277

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Stephen D. Antrobus, M.D.?

Tedicare shows public-source Medicare data for Stephen D. Antrobus, M.D. (NPI 1629116553), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen D. Antrobus, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stephen D. Antrobus, M.D.?

Stephen D. Antrobus, M.D. is linked to MOHS SURGERY SPECIALISTS, LLC (billing NPI 1871626903) in the available physician profile data.

Does Stephen D. Antrobus, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.